FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Luciano Masini

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Michele Cavo; Claudia Crippa; Valerio De Stefano; Daniele Derudas; Maria Laura Dessanti; Daniela Donnarumma; Antonietta Falcone; Felicetto Ferrara; Anna Furlan; Mariella Grasso; Magda Marcatti; Luciano Masini; Pellegrino Musto; Andrea Nozza; Chiara Nozzoli; Antonio Palumbo; Lucia Pantani; Francesca Patriarca; Giulia Perrone; Maria Teresa Petrucci; Annalisa Pezzi; Elena Zamagni; Renato Zambello; Stelvio Ballanti; Anna Baraldi; Mario Boccadoro; Annamaria Brioli; Catello Califano; Vincenzo Callea; Angelo Michele Carella
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.
Stefano Sacchi; Maria Luigia Vigliotti; Alessandra Zoboli; Nicola Di Renzo; Fortunato Morabito; Pellegrino Musto; Santo Neri; Alessandro Pastorini; Giuseppe Polimeno; Giovanni Quarta; Enrico Balleari; Gabriele Buda; Ugo Consoli; Raimondo Ferrara; Alberto Fragasso; antonio lazzaro; Raffaella Marcheselli; Luciano Masini
A randomized trial with melphalan and prednisone versus melphalan and prednisone plus thalidomide in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplant.
Michele Cavo; Patrizia Tosi; Elena Zamagni; Claudia Cellini; Paola Tacchetti; Francesca Patriarca; Francesco Di Raimondo; Ettore Volpe; Sonia Ronconi; Delia Cangini; Franco Narni; Affra Carubelli; Luciano Masini; Lucio Catalano; Mauro Fiacchini; Antonio de Vivo; Alessandro Gozzetti; antonio lazzaro; Sante Tura; Michele Baccarani
Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Luciano Masini (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Michele Cavo; Claudia Crippa; Valerio De Stefano; Daniele Derudas; Maria Laura Dessanti; Daniela Donnarumma; Antonietta Falcone; Felicetto Ferrara; Anna Furlan; Mariella Grasso; Magda Marcatti; Luciano Masini; Pellegrino Musto; Andrea Nozza; Chiara Nozzoli; Antonio Palumbo; Lucia Pantani; Francesca Patriarca; Giulia Perrone; Maria Teresa Petrucci; Annalisa Pezzi; Elena Zamagni; Renato Zambello; Stelvio Ballanti; Anna Baraldi; Mario Boccadoro; Annamaria Brioli; Catello Califano; Vincenzo Callea; Angelo Michele Carella
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.
Blood 2012;120(1):9-19.
2011: Stefano Sacchi; Maria Luigia Vigliotti; Alessandra Zoboli; Nicola Di Renzo; Fortunato Morabito; Pellegrino Musto; Santo Neri; Alessandro Pastorini; Giuseppe Polimeno; Giovanni Quarta; Enrico Balleari; Gabriele Buda; Ugo Consoli; Raimondo Ferrara; Alberto Fragasso; antonio lazzaro; Raffaella Marcheselli; Luciano Masini
A randomized trial with melphalan and prednisone versus melphalan and prednisone plus thalidomide in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplant.
Leukemia & lymphoma 2011;52(10):1942-8.
2007: Michele Cavo; Patrizia Tosi; Elena Zamagni; Claudia Cellini; Paola Tacchetti; Francesca Patriarca; Francesco Di Raimondo; Ettore Volpe; Sonia Ronconi; Delia Cangini; Franco Narni; Affra Carubelli; Luciano Masini; Lucio Catalano; Mauro Fiacchini; Antonio de Vivo; Alessandro Gozzetti; antonio lazzaro; Sante Tura; Michele Baccarani
Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(17):2434-41.
2007: Samantha Pozzi; Raffaella Marcheselli; Stefano Sacchi; Luca Baldini; Francesco Angrilli; Elsa Pennese; Giovanni Quarta; Caterina Stelitano; Giuseppe Caparotti; stefano luminari; Pellegrino Musto; Donato Natale; Chiara Broglia; Angela Cuoghi; Daniele Dini; Paolo Di Tonno; Giovanna Leonardi; Graziano Pianezze; Vincenzo Pitini; Giuseppe Polimeno; Luisa Ponchio; Luciano Masini; Maurizio Musso; Mauro Spriano; Giuseppe Pollastri
Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients.
Leukemia & lymphoma 2007;48(1):56-64.
2002: Michele Cavo; Elena Zamagni; Claudia Cellini; Patrizia Tosi; Delia Cangini; Michela Cini; Lelia Valdrè; Gualtiero Palareti; Luciano Masini; Sante Tura; Michele Baccarani
Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy.
Blood 2002;100(6):2272-3.
2002: Patrizia Tosi; Elena Zamagni; Claudia Cellini; Sonia Ronconi; Francesca Patriarca; Filippo Ballerini; Pellegrino Musto; Francesco Di Raimondo; Antonio Ledda; Francesco Lauria; Luciano Masini; marco gobbi; Angelo Vacca; Roberto Ria; Delia Cangini; Sante Tura; Michele Baccarani; Michele Cavo
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma.
Haematologica 2002;87(4):408-14.